Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Preferred Dividend Payments (2023)

Kiora Pharmaceuticals (KPRX) has disclosed Preferred Dividend Payments for 2 consecutive years, with $530985.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Preferred Dividend Payments changed N/A year-over-year to $530985.0, compared with a TTM value of $530985.0 through Dec 2024, changed 0.0%, and an annual FY2023 reading of $530985.0, changed N/A over the prior year.
  • Preferred Dividend Payments was $530985.0 for Q3 2023 at Kiora Pharmaceuticals, down from $8.2 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $530985.0 in Q3 2023 and bottomed at $530985.0 in Q3 2023.